Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Reata Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering

IRVING, Texas, May 25, 2016 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. ("Reata"), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 5,500,000 shares of its Class A common stock at $11.00 per share, before underwriting discounts and commissions. Reata has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its Class A common stock at the initial public offering price. The shares of Class A common stock are expected to begin trading on The NASDAQ Global Market on May 26, 2016, under the ticker symbol "RETA."

Read the entire Press Release HERE

SHARE

FacebookTwitterLinkedInYoutube
michelle-h.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News


Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator